Ephedraceae as a Treatment for Hyperlipidemia and Hyperglycemia: An Experimental Study

The present study was carried out to evaluate the antidiabetic and anti hyperlipidemic activity of Ephedra in streptozotocin induced diabetic rats. 40 male BALB/cArc Wistar rats aged eight to ten weeks (200 to 250 g) were randomly divided into 4 groups. No statistically significant difference was observed in body weight between the healthy group (A) and other groups before the trial. There was a significant differences between the diabetic and healthy groups. STZ injection was done in groups B and D, the mean blood glucose level increased notably in groups B and D on the 3rd day in comparison with other groups. The result shows that Ephedra extract can be used to control diabetes and absence of acute toxicity may offer a new hope to the diabetics in future.


Shojaie Mohammad, Hosseinpoor Masoumeh*, Jelodar Gholamali and Tavanaie Hoda

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • 2nd International Conference on Autoimmunity November 06-07, 2017 Frankfurt, Germany
    November 06-07, 2017 Frankfurt, Germany
  • World Immunology Congress Dec 14-15, 2017 Dubai, UAE
    Dec 14-15, 2017 Dubai, UAE
Flyer image

Abstracted/Indexed in

  • Index Copernicus
  • Google Scholar
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Geneva Foundation for Medical Education and Research